Not from Advocate Aurora Health? Click the title link for additional options to access full-text. For best viewing, we recommend Google Chrome.

Follow

Works from 2019

Link

Racial disparity in gastrointestinal cancer: insight from national cancer database, Maharaj Singh, Samit K. Datta, Wesley Papenfuss, et al. (Abstract)

Link

Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass, Haiyan Bao, Juehua Gao, Yi-Hua Chen, et al. (Article)

Link

Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital: Focus on cardiovascular patients, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)

Link

Sexual quality of life after the treatment of gynecologic cancer: what women want, J L Hubbs, Elizabeth L. Dickson Michelson, R I Vogel, et al. (Article)

Link

Squamous cell carcinoma of the tongue with metastasis to myocardium: Report of a case and literature review, Ali Shafiq, Fatima Samad, Eric Roberts, et al. (Article)

Link

Survival outcomes between surgery with adjuvant therapy compared to neoadjuvant therapy with surgery in stage I pancreatic adenocarcinoma: Results from a large national cancer database, Samit K. Datta, Geoffrey Belini, Maharaj Singh, et al. (Abstract)

Link

Survival outcomes comparable between endoscopic resection and surgical resection, Samit K. Datta, Geoffrey Belini, Maharaj Singh, et al. (Abstract)

Link

TP53 status as a determinant of pro- versus anti-tumorigenic effects of estrogen receptor-beta in breast cancer, Utpal K Mukhopadhyay, Chetan C Oturkar, Christina Adams, et al. (Article)

Use of treatment pathways reduce cost and decrease ED utilization and unplanned hospital admissions in patients (pts) with stage II breast cancer, James Weese, Corey J. Shamah, Federico A. Sanchez, et al. (Abstract)

PDF

Variability in sentinel lymph node biopsy retrieval for breast cancer at Aurora Health Care, Aaron H. Chevinsky, Judy A. Tjoe, William L. Owens, et al. (Abstract)

Works from 2018

Link

A global treatment standard in multiple myeloma (MM) remains elusive despite advances in care over 15 years: first results from INSIGHT MM, the largest global prospective, observational MM study, Caitlin L. Costello, Mario Boccadoro, Michael A. Thompson, et al. (Abstract)

Link

Androgen deprivation therapy for prostate cancer and incident atrial fibrillation, Zuber S. Ali, Tadele Mengesha, Suhail Allaqaband, et al. (Poster)

Link

Association of 70-gene signature assay findings with physicians' treatment guidance for patients with early breast cancer classified as intermediate risk by the 21-gene assay, Michaela Tsai, Shelly Lo, William Audeh, et al. (Article)

Link

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) on social media: #BPDCN-increasing exposure over two years since inception of a disease-specific twitter community, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al. (Article)

Link

BRD4 inhibition Is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency, Chaoyang Sun, Jun Yin, Yong Fang, et al. (Article)

Link

Can we improve nonmuscle invasive bladder cancer guideline adherence with smarter risk stratification?, Tracy M Downs, John Weissert, and Kourosh Ravvaz (Editorial)

Link

Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions, Sanjay Bhandari, Mubeen Khan Mohammed Abdul, Will Hollabaugh, et al. (Article)

Link

Differential regulation of human monocytes and NK cells by antibody-opsonized tumors, Jun Yin, Alex J. Albers, Thomas S. Smith, et al. (Article)

Drug-specific videos for patient chemotherapy education, James Weese, Kerry A. Twite, Marija Bjegovich-Weidman, et al. (Article)

PDF

Drug targeting: repurposing FDA therapeutic drugs to treat triple-negative breast cancer, Paul J. Mintz, Jerald Smith, Andrea Sand, et al. (Abstract)

Factors influencing first-line therapy of acute myeloid leukemia (AML) patients (pts) in the Connect MDS/AML Disease Registry, Christopher R Cogle, Michael A. Thompson, and et al (Abstract)

Link

Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome, Matthew Walters, Mark R Pittelkow, Robert P Hasserjian, et al. (Article)

Identification, prioritization, and treatment of mutations identified by next-generation sequencing, Aaron S Mansfield, Ben Ho Park, and Michael P. Mullane (Book Chapter)

Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices, J L. Ersek, L J. Black, Michael A. Thompson, et al. (Book Chapter)

Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices, Jennifer L Ersek, Lora J Black, Michael A. Thompson, et al. (Book Chapter)

PDF

Initiation of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) program at Aurora Health Care, Aaron H. Chevinsky, Wesley Papenfuss, Federico A. Sanchez, et al. (Abstract)

Link

Lower extremity weakness in an adolescent female - a rare presentation of Ewing sarcoma, Luke Addesso, David Koenig, and Nadia Huq (Article)

Link

Metastatic recurrent hepatocellular carcinoma post liver transplant with marked pretransplant elevation of alpha fetoprotein and no evidence of primary neoplasm, Shiva Kumar (Article)

Link

MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and survivin inhibition and enhances response to temozolomide, George C. Bobustuc, Amin B. Kassam, Richard Rovin, et al. (Article)

Multidisciplinary management of oligometastatic soft tissue sarcoma, Juneko E Grilley-Olson, Nicholas P. Webber, David S. Demos, et al. (Book Chapter)

Link

Non-human papillomavirus cervical mucinous adenocarcinoma in a phenotypic male with congenital adrenal hyperplasia, Jennifer Heim, Elizabeth L. Dickson, Melissa Aa Geller, et al. (Article)

Link

One pulmonary lesion, 2 synchronous malignancies, Masooma Aqeel, Nevin Uysal-Biggs, Timothy S Fenske, et al. (Article)

Precision medicine/genetics: Advocate Aurora Health cancer screening updates for the primary care clinician, Michael A. Thompson and Michael P. Mullane (Oral/Podium Presentation)

Link

Promoting team-based exercise among African American breast cancer survivors, Linda B Piacentine, Karen M Robinson, Leslie J. Waltke, et al. (Article)

Link

Quantifying the effect of air gap, depth, and range shifter thickness on TPS dosimetric accuracy in superficial PBS proton therapy, Robert J. Shirey and Hsinshun Terry Wu (Article)

PDF

Racial Disparity Among Women Diagnosed With Invasive Breast Cancer in a Large Integrated Health System, Maharaj Singh, Santhi D. Konduri, George C. Bobustuc, Amin B. Kassam, and Richard A. Rovin (Original Research)

Reportable actionability versus pragmatic actionability: Implementing precision medicine at three large health systems, Michael A. Thompson, James Weese, Maharaj Singh, et al. (Abstract)

Link

Sentinel lymph node mapping in endometrioid endometrial cancer: does it work in the real world? [22A], Olga Valieva, Danielle M. Greer, Jessica J. Kram, et al. (Abstract)

Link

Social media and clinical trials: The pros and cons gain context when the patient is at the center, Michael A. Thompson and Ruth M O'Regan (Article)

Successful automated normalization of cancer outcomes for half a million patients across four disparate health systems, Paul D. Tittel, Michael A. Thompson, James Weese, et al. (Abstract)

The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, et al. (Article)

The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, et al. (Article)

PDF

The Needs of Women Treated for Ovarian Cancer: Results From a #gyncsm Twitter Chat, Teresa Hagan Thomas, Karin Nauth-Shelley, Michael A. Thompson, Deanna J. Attai, Matthew S. Katz, David Graham, Dee Sparacio, Christina Lizaso, Audun Utengen, and Don S. Dizon (Original Research)

Link

The survival effect of repeat surgery at glioblastoma recurrence and its trend: a systematic review and meta-analysis, Victor M Lu, Toni R Jue, Kerrie L McDonald, et al. (Article)

Works from 2017

Analysis of the use and impact of Twitter during American Society of Clinical Oncology annual meetings from 2011 to 2016: Focus on advanced metrics and user trends, Naveen Pemmaraju, Michael A. Thompson, Ruben A Mesa, et al. (Article)

Best practices and practical nuances in the treatment of gastric cancer in high-risk global areas, Federico A. Sanchez (Article)

BRE12-158: A phase II randomized controlled trial of genomically directed therapy after preoperative chemotherapy in patients with triple negative breast cancer (TNBC), B Schneider, K D. Miller, S Badve, et al. (Abstract)

Competitive funding strategies for the conquer cancer foundation of ASCO, Tanios Bekaii-Saab, Sanjay Goel, Adrien Dickerson, et al. (Article)

PDF

Disulfram enhances Palbociclib and Abemaciclib activity through MGMT and CDK4/6 inhibition in breast cancer cells, Santhi Konduri, Deborah Donohoe, Dmitry Bosenko, et al. (Poster)

Enhanced recovery program and length of stay after laparotomy on a gynecologic oncology service: A randomized controlled trial, Elizabeth L. Dickson, Erica Stockwell, Melissa A Geller, et al. (Article)

PDF

Generation of a Patient-Derived Brain Metastasis Breast Cancer Cell Line via Novel Orthotopic Injection Placement and Serial Mouse Transplantation to Develop PDX Mouse Model, Amber L. LaCrosse, Denise M. Coley, Paul J. Mintz, Santhi D. Konduri, Richard A. Rovin, and Amin B. Kassam (Supplement)

PDF

Hormonal contraception and therapy use in breast cancer survivors: Do recurrence and mortality risks increase?, Sara Stanenas, Danielle M. Greer, Jessica J F Kram, et al. (Abstract)

PDF

Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response, Michael A. Thompson, Martin K. Oaks, Maharaj Singh, Karen M. Michel, Michael P. Mullane, Husam S. Tarawneh, Angi Kraut, and Kayla J. Hamm (Brief Report)

PDF

Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study, Andinet Alemu, Maharaj Singh, Chris Blumberg, John O. Richards, Martin K. Oaks, and Michael A. Thompson (Original Research)

Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553), Susanne M Arnold, Kari Chansky, Markos Leggas, et al. (Article)

Practice model for advanced practice providers in oncology, Jamie Cairo, Mary Ann Muzi, Deanna Ficke, et al. (Article)

Predicting nonmuscle invasive bladder cancer recurrence and progression in a United States population, Kourosh Ravvaz, Marcus E Walz, John Weissert, et al. (Article)

Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment, Jeffrey S Weber, Laura A Levit, Peter C Adamson, et al. (Article)

PDF

Robustness of a Newly Proposed Risk Schema for Lymphatic Dissemination in Endometrioid Endometrial Cancer, Danielle M. Greer, Jessica J.F. Kram, Callie M. Cox Bauer, and Scott A. Kamelle (Supplement)

PDF

Robustness of a newly proposed risk schema for lymphatic dissemination of endometrioid endometrial cancer, Danielle M. Greer, Jessica J F Kram, Callie M. Cox Bauer, et al. (Poster)

The emerging role of professional social media use in oncology, Mina S Sedrak, Don S Dizon, Patricia F Anderson, et al. (Editorial)

Triathlon training for women breast cancer survivors: feasibility and initial efficacy, Alexander V Ng, Alyson N Cybulski, Ashley A Engel, et al. (Article)

Works from 2016

Abstract 2594: clinical pathways as a platform to support clinical research, Peter G. Ellis (Abstract)

Abstract 285: Disulfiram, a dual MGMT and aldehyde dehydrogenase inhibitor, sensitizes ER-positive breast cancer cells to temozolomide and cyclophosphamide, George C. Bobustuc, Deborah Donohoe, Alisher Holmuhamedov, et al. (Abstract)

Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: outcomes from CALGB 40603 (Alliance), WM Sikov, DA Berry, CM Perou, et al. (Abstract)

Actionable biomarkers in a non-small cell lung cancer (NSCLC) clinical pathway (CP), Peter G. Ellis (Abstract)

Addressing administrative and regulatory burden in cancer clinical trials: Summary of a stakeholder survey and workshop hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes, Julie M Vose, Laura A Levit, Patricia Hurley, et al. (Article)

An online tool to assess the quality of research programs, Renee Yvonne Smith, Patricia A. Hurley, Michael A. Thompson, et al. (Abstract)

PDF

A Pilot Study of Circulating Tumor Cells in Stage IV Non-Small Cell Lung Carcinoma, Max Haid, Edward Chesna, Mary Theodoroff, Debra K. Spaeth, Cheruppolil R. Santhosh-Kumar, and Zahid N. Dar (Original Research)

Bell’s palsy as the initial presentation of multiple myeloma: A case report, Qiaofang Chen, Carol Huibregtse, and Cheruppolil R. Santhosh-Kumar (Case Report)

Breast cancer diagnosed by stress SPECT sestamibi: The role of inverse gray-scale imaging, Khawaja Afzal Ammar, Armaan Shaikh, Michael Anigbogu, et al. (Article)

Challenges with research contract negotiations in community-based cancer research, Michael A. Thompson, Patricia A Hurley, Bryan Faller, et al. (Article)

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study, David P Steensma, Medrdad Abedi, Rafael Bejar, et al. (Article)

Current diagnosis patterns for acute myeloid leukemia (AML) in clinical practice compared with World Health Organization (WHO) 2008 recommendations: outcomes from the CONNECT® Myelodysplastic Syndromes (MDS) and AML disease registry, Tracy I. George, Harry P. Erba, David P. Steensma, et al. (Abstract)

PDF

Determining the Incidence and Factors of Cardiotoxicity in Breast Cancer Patients Treated With Anthracycline and/or Trastuzumab-Containing Regimen at Aurora Health Care, Stephanie Ghojallu, Matthew Rappelt, Han-Yang Chen, Ruth Perez, Lydia Garlie, Geoffrey Riddell, Yingying Gu, Jun Zhang, Rubina Qamar, Bijoy K. Khandheria, Arshad Jahangir, and Yang Shi (Supplement)

Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells, Johnathan E Lawrence, Christopher J Steele, Richard A Rovin, et al. (Article)

Disease-specific hashtags for online communication about cancer care, Matthew S Katz, Audun Utengen, Patricia F Anderson, et al. (Article)

Effect on clinical trial participation by integration of a clinical pathway program into an electronic health record (EHR), Corey J. Shamah and Thomas J. Saphner (Abstract)

Engaging managing physicians in clinical staging prior to the initiation of cancer treatment, Anne Barry-Weers, Carol Huibregtse, Marija Bjegovich-Weidman, et al. (Abstract)

Erratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S. Smith, et al. (Article)

Extradigital glomus tumor: a rare etiology for wrist soft tissue mass, Justin E. Friske, Vipul Sharma, S A. Kolpin, et al. (Case Report)

Global, prospective, non-interventional, observational study of presentation, treatment patterns, and outcomes in multiple myeloma patients: the Insight-MM Study, Robert M. Rifkin, Faith E. Davies, Antonio Palumbo, et al. (Abstract)

Implementation of treatment pathways in a large integrated health care system, James Leighton Weese, Levi Citrin, Corey J. Shamah, et al. (Abstract)

Implementing survivorship care planning in a large integrated cancer program, M. Jamie Cairo, Carol Huibregtse, Adam Ferry, et al. (Abstract)

Insights from building a new National Cancer Institute Community Oncology Research Network Program site, Thomas J. Saphner, Michael A. Thompson, Sara Planton, et al. (Article)

Integration of a clinical pathways software into an EHR in a large, multisite, hospital-affiliated community oncology setting, Corey J. Shamah, Thomas J. Saphner, Jacob C. Frick, et al. (Abstract)

Measures of appropriateness and value for breast surgeons and their patients: the american society of breast surgeons choosing wisely (®) initiative, Jeffrey Landercasper, Lisa Bailey, Tiffany S Berry, et al. (Article)

Metastatic bone disease: femur—tibia, Nicholas Webber (Book Chapter)

PDF

MGMT inhibition by disulfiram sensitizes ER+ breast cancer cells to temozolomide and cyclophosphamide, Santhi Konduri, Deborah Donohoe, Alisher Holmuhamednov, et al. (Poster)

Multiple myeloma vaccination sequential immune response pilot study, Michael A. Thompson, Martin K. Oaks, John O Richards, et al. (Abstract)

New insights into estrogenic regulation of O(6)-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O(6)-benzylguanine indicates fresh avenues for therapy, Ameya Paranjpe, Nathan I Bailey, Santhi Konduri, et al. (Article)

New primary palliative care (PC) model for community cancer clinics (CCC), Cheruppolil R. Santhosh-Kumar, Deborah Gray, Stephanie Struve, et al. (Abstract)

NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S Smith, et al. (Article)

Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis, Zeeshan Jawa, Ruth M Perez, Lydia Garlie, et al. (Article)

Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance, Pranshu Mohindra, Erich Urban, Jonathan D Pagan, et al. (Article)

Social media and internet resources for patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn), Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, et al. (Article)

Social media and myeloproliferative neoplasms (mpn): analysis of advanced metrics from the first year of a new twitter community: #mpnsm, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al. (Article)

Social media in cancer care: highlights, challenges & opportunities, Deanna J Attai, Mina S Sedrak, Matthew S Katz, et al. (Article)

Social media in cancer care: highlights, challenges & opportunities, Deanna J Attai, Mina S Sedrak, Matthew S Katz, et al. (Article)

Survivors speak: a qualitative analysis of motivational factors influencing breast cancer survivors' participation in a sprint distance triathlon, Karen M Robinson, Linda B Piacentine, Leslie J. Waltke, et al. (Article)